TMS Therapy in Dallas

Premier Pain Centers offers FDA-cleared Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression and OCD as a safe, non-invasive, drug-free option when medications haven’t worked.

Schedule an Appointment

CLINICAL TRANSPARENCY

Indications & Approvals

FDA-Cleared Indications

We believe in full transparency. Below is a clear breakdown of FDA-cleared indications.

Major Depressive Disorder (MDD)

FDA-cleared for adults with treatment-resistant depression who have not responded to one or more antidepressant medications. Primary and strongest indication with extensive clinical evidence.

🗓 First FDA cleared: 2008

Obsessive-Compulsive Disorder (OCD)

FDA-cleared deep TMS protocol targeting the medial prefrontal cortex and anterior cingulate cortex. Demonstrated significant symptom reduction in controlled trials.

🗓 FDA cleared for OCD

Smoking Cessation

A specific FDA-cleared TMS protocol (BrainsWay device) approved to help patients quit smoking as part of a comprehensive cessation program.

🗓 Device-specific indication

Migraine with Aura

Single-pulse TMS (SpringTMS device) is FDA-cleared for acute treatment and prevention of migraine with aura — a distinct neurological indication.

🗓 Separate neurological device

The Process

How TMS Therapy Works

Psychiatric Evaluation

A licensed psychiatrist reviews your history, confirms diagnosis, and determines if you meet criteria for TMS — including prior antidepressant treatment failures for MDD.

Personalized Treatment Map

Motor threshold testing calibrates the precise magnetic field strength needed for your individual brain anatomy before treatment begins.

Treatment Sessions

Sit comfortably in an outpatient office. A coil delivers focused magnetic pulses to the prefrontal cortex. Sessions last 20–40 minutes, 5 days/week for 4–6 weeks.

Progress Monitoring

Your psychiatrist monitors response using validated depression rating scales and adjusts treatment parameters as needed throughout the course.

🧠

Targeted Neurological Stimulation

TMS delivers precise magnetic pulses to the left dorsolateral prefrontal cortex (DLPFC) — consistently shown to be underactive in treatment-resistant depression. This stimulates neuroplasticity, helping the brain build healthier activity patterns over time.

4–6 wks

Sessions

20–40 min

Duration

5x/week

Frequency

Evidence-Based Medicine

What Clinical Research Shows

TMS for MDD and OCD is supported by multiple randomized controlled trials and recognized by the APA as safe and evidence-based when administered by trained clinicians.

50–60%

Response Rate in MDD

Clinical trials show 50–60% of treatment-resistant depression patients experience significant symptom reduction with TMS therapy.

Source: Multiple RCTs; APA Practice Guidelines

30–35%

Full Remission in MDD

Approximately one-third of patients with treatment-resistant depression achieve full remission following a complete TMS treatment course.

Source: NeuroStar clinical trial data

6–12 mo

Durability of Response

Studies show sustained remission in select patients for 6–12 months post-treatment, with maintenance sessions available if needed.

Source: Long-term follow-up studies

Moderate

OCD Evidence Level

Deep TMS for OCD demonstrated significant reduction in Y-BOCS scores in pivotal FDA-registration trials with active vs. sham comparisons.

Source: BrainsWay OCD trial, 2019

Early

Anxiety, PTSD, ADHD

Evidence is preliminary. Clinical trials are ongoing but current data is insufficient for standard FDA approval or routine insurance coverage.

Status: Off-label / Experimental

APA

Professional Endorsement

The American Psychiatric Association supports TMS as evidence-based for MDD when administered by trained psychiatrists with appropriate monitoring.

Source: APA Practice Guidelines, 2022

Safety Profile

Is TMS Safe?

TMS is FDA-cleared and considered very safe. Unlike systemic medications, it acts locally on targeted brain regions without affecting the rest of the body.

No Medication

Zero systemic drugs. No risk of medication interactions, weight gain, or sexual side effects associated with antidepressants.

No Anesthesia

Fully conscious, outpatient treatment. No sedation, no recovery room, no hospital admission required.

No Downtime

Patients resume normal daily activities — including driving and work — immediately after each session.

Minimal Side Effects

Most common: mild headache or scalp tingling at the treatment site, typically resolving quickly after each session.

Our Results

Patient Outcomes at Premier Pain Centers

Based on patient-reported data from our Dallas-area clinics among patients receiving TMS for FDA-cleared indications (primarily treatment-resistant MDD).

94%

Reported Improvement in Depression Symptoms

Among MDD patients completing a full treatment course

59%

Achieved Remission from Depressive Episodes

Sustained response at 6-week post-treatment evaluation

97%

Highly Satisfied with TMS Care Provided

Patient satisfaction survey across Dallas locations

Insurance Coverage for TMS

Coverage varies by plan and diagnosis. We verify your specific benefits before treatment begins to avoid any surprises.

✓Typically Covered

✓Treatment-resistant MDD — after documented failure of 1+ antidepressant trials. Most major insurers: Medicare, Aetna, BCBS, Cigna, UnitedHealthcare.
✓OCD — with supporting psychiatric documentation and prior authorization approval.
✓Prior authorization is required — our team handles this process on your behalf.
✓Medical necessity documentation prepared by our board-certified psychiatrists.

⚠Coverage Varies or May Not Apply

✗Primary anxiety disorders — not consistently covered as a standalone indication. May require off-label justification.
✗PTSD, Bipolar, ADHD — generally not covered due to lack of FDA approval for TMS. Off-label coverage is rare and plan-specific.
✗Self-pay options available for off-label cases evaluated individually by our clinical team.

Important: Coverage statements reflect general trends and are not a guarantee. Coverage depends on your specific plan, diagnosis, and medical necessity documentation. Our team conducts a detailed benefits verification before any treatment begins.

Book Your Appointment

Book an Appointment at Premier Pain Centers with Dr. Rao Ali

FAQ's

The Answers to Your Questions

Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA-cleared treatment that uses gentle magnetic pulses to stimulate specific regions of the brain. It does not require anesthesia, surgery, or hospital stay, and patients can resume normal activities immediately after each session.

TMS is FDA-cleared for: (1) Treatment-resistant Major Depressive Disorder (MDD) in adults who have not responded to antidepressant medications, (2) Obsessive-Compulsive Disorder (OCD), (3) Smoking Cessation (BrainsWay device), and (4) Migraine with Aura (single-pulse device). Use for anxiety, PTSD, bipolar disorder, and ADHD is considered off-label and requires individual clinical evaluation.

Most major insurance providers cover TMS for FDA-approved indications — primarily treatment-resistant depression (MDD) — when specific medical necessity criteria are met, including documented failure of prior antidepressant treatments. Coverage for other conditions varies by plan and may require individual prior authorization. Our team will verify your specific benefits before treatment begins.

A TMS coil is placed near the scalp and delivers precisely targeted magnetic pulses to the prefrontal cortex — the area involved in mood regulation. These pulses stimulate underactive nerve cells, promoting neuroplasticity. Treatment typically involves 5 sessions per week over 4–6 weeks, with each session lasting 20–40 minutes.

Yes. TMS is considered very safe and well-tolerated by leading psychiatric organizations including the APA. It does not involve surgery, anesthesia, or systemic medication. The most common side effects are mild headache or scalp discomfort at the treatment site, which typically resolve quickly. Serious adverse events are rare.